Previous 10 | Next 10 |
Arcus Biosciences (NYSE: RCUS ) initiated with Buy rating and $22 (150% upside) price target at Mizuho Securities. More news on: Arcus Biosciences, Inc., Stealth BioTherapeutics Corp, HOOKIPA Pharma Inc., Healthcare stocks news, Stocks on the move, , Read more ...
Applied Genetic Technologies Corporation (NASDAQ:AGTC) Q4 2019 Earnings Conference Call September 26, 2019 4:30 PM ET Company Participants Sue Washer - Chief Executive Officer Bill Sullivan - Chief Financial Officer Mark Shearman - Chief Scientific Officer Theresa Heah - Chi...
The following slide deck was published by Applied Genetic Technologies Corporation in conjunction with their 2019 Q4 earnings Read more ...
Applied Genetic (NASDAQ: AGTC ): Q4 GAAP EPS of -$0.58 misses by $0.04 . More news on: Applied Genetic Technologies Corporation, Earnings news and commentary, Healthcare stocks news, , Read more ...
Company announces promising topline six-month dose escalation data from its ongoing Phase 1/2 clinical trials for X-linked retinitis pigmentosa (XLRP) Preliminary three-month XLRP dose expansion data demonstrates improvement in 50% of centrally dosed patients Early data from both ...
GAINESVILLE, Fla., and CAMBRIDGE, Mass., Sept. 18, 2019 (GLOBE NEWSWIRE) -- Applied Genetic Technologies Corporation (Nasdaq: AGTC), a biotechnology company conducting human clinical trials of adeno-associated virus (AAV)-based gene therapies for the treatment of rare diseases, today announ...
GAINESVILLE, Fla. and CAMBRIDGE, Mass., Aug. 28, 2019 (GLOBE NEWSWIRE) -- Applied Genetic Technologies Corporation (Nasdaq: AGTC), a biotechnology company conducting human clinical trials of adeno-associated virus (AAV)-based gene therapies for the treatment of rare diseases, today announce...
TRENTO, Italy, Aug. 14, 2019 (GLOBE NEWSWIRE) -- The Italian Achromatopsia Association (IAA) today announced that it is organizing a trip to Pingelap, a remote Micronesian atoll in the South Pacific, also known as the “Island of the Color Blind . ” While the incidence of achro...
GAINESVILLE, Fla., and CAMBRIDGE, Mass., Aug. 07, 2019 (GLOBE NEWSWIRE) -- Applied Genetic Technologies Corporation (Nasdaq: AGTC), a biotechnology company conducting human clinical trials of adeno-associated virus (AAV)-based gene therapies for the treatment of rare diseases, today announc...
The following slide deck was published by Applied Genetic Technologies Corporation in conjunction with this Read more ...
News, Short Squeeze, Breakout and More Instantly...
Applied Genetic Technologies Corporation Company Name:
AGTC Stock Symbol:
NASDAQ Market:
Applied Genetic Technologies Corporation Website:
GAINESVILLE, Fla. and CAMBRIDGE, Mass., Nov. 29, 2022 (GLOBE NEWSWIRE) -- Applied Genetic Technologies Corporation (“AGTC” or the “Company”) (Nasdaq: AGTC), announced today that a portfolio company of Syncona Limited (LON: SYNC) (“Syncona”) has exte...
GAINESVILLE, Fla. and CAMBRIDGE, Mass., Nov. 28, 2022 (GLOBE NEWSWIRE) -- Applied Genetic Technologies Corporation (Nasdaq: AGTC), President and Chief Executive Officer, Sue Washer, reminds AGTC stockholders: A Syncona Limited portfolio company has commenced a tender offer to purcha...
GAINESVILLE, Fla. and CAMBRIDGE, Mass., Nov. 22, 2022 (GLOBE NEWSWIRE) -- Applied Genetic Technologies Corporation (Nasdaq: AGTC), President and Chief Executive Officer, Sue Washer, reminds AGTC stockholders: A Syncona Limited portfolio company has commenced a tender offer to purcha...